Literature DB >> 12114701

Immunocytochemical Localization of Glucose Transporter-2 (GLUT-2) in Pancreatic Islets and Islet Cell Tumors.

Tatsuo Tomita.   

Abstract

Glucose is a major metabolic fuel in mammals and is transported into organs and cells by a facilitated diffusion which involves binding of glucose to glucose transporters (GLUTs). Among several GLUTs so far indentified, GLUT-2 is specifically localized immunocytochemV cally in beta-islet cells. Using immunocytochemical staining, normal pancreases and 27 cases of islet cell tumors, including insulinomas, gastrinomas, glucagonomas, pancreatic polypeptide-omas (PPomas), and a nonfunctioning islet cells tumor, were systematically stained for four different pancreatic hormones, gastrin, and GLUT-2. GLUT-2 staining in beta-islet cells was more diffuse than that of insulin immunostaining, and corresponded with the positive staining in the lateral segments of beta-cell plasma membrane, that faced adjacent beta-cells. Glucagon, somatostatin (SRIF) and PP cells stained weakly for GLUT-2, weaker than that of beta-cells. Some nonbeta cells, especially extra-islet PP cells were not stained for GLUT-2. Among islet cell tumors, insulinomas stained less strongly for GLUT-2 than normal beta-cells from the adjacent normal pancreas. Gastrinomas, glucagonomas, and PPomas stained weaker than insulinomas. Even nonfunctioning islet cell tumors were weakly stained for GLUT-2. The positive staining for GLUT-2 observed for islets cells and all islet tumors is consistent with the notion that all pancreatic islet cells and islet cell tumors utilize glucose as a major fuel, requiring transporter-facilitated diffusion of glucose into the cells of normal organ and their tumors.

Entities:  

Year:  1999        PMID: 12114701     DOI: 10.1007/bf02738882

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  26 in total

Review 1.  Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter.

Authors:  B Thorens
Journal:  Int Rev Cytol       Date:  1992

2.  A newly recognized pancreatic polypeptide; plasma levels in health and disease.

Authors:  J C Floyd; S S Fajans; S Pek; R E Chance
Journal:  Recent Prog Horm Res       Date:  1976

Review 3.  Immunohistochemical localization of chromogranin in normal and neoplastic endocrine tissues.

Authors:  R V Lloyd
Journal:  Pathol Annu       Date:  1987

Review 4.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

Review 5.  The pancreatic beta-cell glucose sensor.

Authors:  S Efrat; M Tal; H F Lodish
Journal:  Trends Biochem Sci       Date:  1994-12       Impact factor: 13.807

6.  Glucose transporter proteins in human insulinoma.

Authors:  G Boden; E Murer; M Mozzoli
Journal:  Ann Intern Med       Date:  1994-07-15       Impact factor: 25.391

7.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

8.  Pancreatic hormones in streptozotocin-diabetic rats.

Authors:  T Tomita; S Sasaki; V Doull; R Bunag; J R Kimmel
Journal:  Int J Pancreatol       Date:  1986-10

9.  Abnormal facilitative glucose transporter gene expression in human islet cell tumors.

Authors:  Y Seino; T Yamamoto; K Inoue; M Imamura; S Kadowaki; H Kojima; J Fujikawa; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1993-01       Impact factor: 5.958

10.  Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.

Authors:  Y Tanizawa; A C Riggs; K C Chiu; R C Janssen; D S Bell; R P Go; J M Roseman; R T Acton; M A Permutt
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

View more
  3 in total

1.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

Review 2.  Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Authors:  Michael S Lee; Bert H O'Neil
Journal:  J Gastrointest Oncol       Date:  2016-10

3.  Modulation of Calcium Homeostasis May Be Associated with Susceptibility to Renal Cell Carcinoma in Diabetic Nephropathy Rats.

Authors:  Yueming Luo; Zhaoyu Lu; Ana Maria Waaga-Gasser; Haifeng Yang; Jialing Liu; Juan Wu; Jiayan Lu; Xusheng Liu; Lei Zhang
Journal:  Cancer Manag Res       Date:  2020-10-07       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.